跳至主要内容
临床试验/JPRN-UMIN000009133
JPRN-UMIN000009133招募中未知

The Effect of Levocarnitine on the Patient with Non-alcoholic Fatty Liver Disease - Levocarnitine for Treatment of Non-alcoholic Fatty Liver Disease

Kanazawa University Graduate School of Medical Science, Disease Contral and Homeostasis0 个研究点目标入组 80 人开始时间: 2012年10月17日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The following patients should be excluded 1. Infected with HBV or HCV 2. Alcohol assumption per day; greater than 20g 3. Complicated with malignant disease including hepatocellular carcinoma 4. Complicated with obvious hepatic encephalopathy 5. Complicated with active infectious disease 6. Complicated with Critical complications 7. Nursing and Pregnant woman 8. Taking contraindicating medicines with Levocarnitine 9. Taking pioglitazone and metformin 10.the other patients who the doctors in charge consider should not enter this study

研究者

发起方
Kanazawa University Graduate School of Medical Science, Disease Contral and Homeostasis

相似试验